Elevance Health, Inc. (NYSE:ELV) Stock Holdings Increased by Todd Asset Management LLC

Todd Asset Management LLC grew its holdings in shares of Elevance Health, Inc. (NYSE:ELV) by 16.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 59,906 shares of the company’s stock after purchasing an additional 8,413 shares during the period. Todd Asset Management LLC’s holdings in Elevance Health were worth $28,249,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of ELV. OFI Invest Asset Management acquired a new position in Elevance Health during the third quarter worth about $25,000. Alaska Permanent Fund Corp bought a new stake in shares of Elevance Health during the 4th quarter worth $31,000. Hexagon Capital Partners LLC grew its holdings in shares of Elevance Health by 63.0% in the 4th quarter. Hexagon Capital Partners LLC now owns 75 shares of the company’s stock worth $35,000 after acquiring an additional 29 shares during the last quarter. ORG Partners LLC acquired a new stake in shares of Elevance Health during the fourth quarter worth $40,000. Finally, Orion Capital Management LLC purchased a new stake in shares of Elevance Health during the third quarter valued at $46,000. 89.24% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, Director Ramiro G. Peru sold 753 shares of Elevance Health stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $500.00, for a total value of $376,500.00. Following the transaction, the director now owns 9,109 shares of the company’s stock, valued at $4,554,500. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other Elevance Health news, Director Ramiro G. Peru sold 753 shares of the company’s stock in a transaction dated Wednesday, February 7th. The shares were sold at an average price of $500.00, for a total transaction of $376,500.00. Following the completion of the sale, the director now directly owns 9,109 shares in the company, valued at $4,554,500. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Felicia F. Norwood sold 14,111 shares of Elevance Health stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $533.74, for a total value of $7,531,605.14. Following the completion of the transaction, the executive vice president now owns 31,460 shares in the company, valued at $16,791,460.40. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

Elevance Health Stock Up 0.3 %

Shares of ELV traded up $1.35 during mid-day trading on Friday, hitting $526.96. 819,445 shares of the company’s stock were exchanged, compared to its average volume of 1,136,492. The stock has a market cap of $122.48 billion, a price-to-earnings ratio of 19.92, a P/E/G ratio of 1.16 and a beta of 0.79. The firm has a fifty day moving average of $513.54 and a two-hundred day moving average of $488.91. The company has a quick ratio of 1.37, a current ratio of 1.37 and a debt-to-equity ratio of 0.54. Elevance Health, Inc. has a twelve month low of $412.00 and a twelve month high of $542.07.

Elevance Health (NYSE:ELV) last posted its earnings results on Thursday, April 18th. The company reported $10.64 EPS for the quarter, topping the consensus estimate of $10.54 by $0.10. Elevance Health had a net margin of 3.64% and a return on equity of 20.62%. The firm had revenue of $42.27 billion for the quarter, compared to the consensus estimate of $42.49 billion. During the same period in the prior year, the business posted $9.46 earnings per share. The business’s quarterly revenue was up .9% on a year-over-year basis. On average, sell-side analysts forecast that Elevance Health, Inc. will post 37.26 earnings per share for the current year.

Elevance Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Investors of record on Monday, June 10th will be issued a $1.63 dividend. The ex-dividend date of this dividend is Monday, June 10th. This represents a $6.52 annualized dividend and a yield of 1.24%. Elevance Health’s dividend payout ratio (DPR) is currently 24.64%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on ELV. UBS Group lifted their target price on shares of Elevance Health from $585.00 to $605.00 and gave the stock a “buy” rating in a research report on Friday, April 19th. Barclays lifted their price target on Elevance Health from $584.00 to $621.00 and gave the company an “overweight” rating in a report on Friday, April 19th. Wells Fargo & Company increased their price objective on Elevance Health from $557.00 to $600.00 and gave the stock an “overweight” rating in a research note on Friday, April 19th. Mizuho lifted their target price on Elevance Health from $575.00 to $585.00 and gave the company a “buy” rating in a research note on Wednesday, April 24th. Finally, Jefferies Financial Group increased their price target on shares of Elevance Health from $602.00 to $604.00 and gave the stock a “buy” rating in a research report on Friday, April 19th. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, Elevance Health has a consensus rating of “Moderate Buy” and a consensus price target of $587.42.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.